Bioduro

中文简体

Let's talk
Contact us
2018.03.05

BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities

Company adds 100,000 tumors to portfolio; enables broad access to proven technology platform

Read more